IRIS Institutional Research Information System - OPENBS Open Archive UniBS

AVENOSO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.273
NA - Nord America 1.106
EU - Europa 638
SA - Sud America 325
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 31
Totale 3.432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.039
SG - Singapore 437
IT - Italia 398
CN - Cina 274
BR - Brasile 266
BD - Bangladesh 187
VN - Vietnam 130
HK - Hong Kong 98
FR - Francia 51
TR - Turchia 41
RU - Federazione Russa 39
GB - Regno Unito 32
CA - Canada 30
IN - India 28
AR - Argentina 23
DE - Germania 23
FI - Finlandia 22
MX - Messico 20
IQ - Iraq 16
ID - Indonesia 14
ES - Italia 13
ZA - Sudafrica 12
NL - Olanda 10
EC - Ecuador 9
MA - Marocco 8
PL - Polonia 8
SA - Arabia Saudita 8
UA - Ucraina 8
UZ - Uzbekistan 8
PY - Paraguay 7
AL - Albania 6
JP - Giappone 6
SE - Svezia 6
VE - Venezuela 6
CH - Svizzera 5
CL - Cile 5
CR - Costa Rica 5
CO - Colombia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
AT - Austria 2
BB - Barbados 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
YE - Yemen 1
Totale 3.373
Salva come PNG Salva come JPEG
Città #
Singapore 245
Ashburn 142
Hong Kong 97
New York 81
San Jose 73
Los Angeles 62
Columbus 57
Ho Chi Minh City 54
Beijing 51
Milan 49
The Dalles 48
Dallas 41
Lauterbourg 40
Buffalo 32
Istanbul 32
São Paulo 32
Council Bluffs 28
Hanoi 27
Brescia 26
Rome 26
Des Moines 22
Moscow 22
Santa Clara 21
Chicago 18
Helsinki 17
Denver 13
Guangzhou 13
Atlanta 12
Mexico City 12
Montreal 12
Turin 12
Orem 11
Brooklyn 10
Naples 10
Chennai 9
Frankfurt am Main 9
Redondo Beach 9
Brasília 8
Manchester 8
San Francisco 8
Toronto 8
Warsaw 8
London 7
Phoenix 7
Rio de Janeiro 7
Tashkent 7
Baghdad 6
Charlotte 6
Curitiba 6
Palermo 6
Stockholm 6
Thái Bình 6
Tokyo 6
Ankara 5
Bari 5
Bologna 5
Bovegno 5
Catania 5
Dhaka 5
Florence 5
Guayaquil 5
Las Vegas 5
Modena 5
Poplar 5
Seattle 5
Blumenau 4
Falkenstein 4
Figino 4
Haiphong 4
Hangzhou 4
Houston 4
Johannesburg 4
Kyiv 4
Munich 4
Novo Hamburgo 4
Nuremberg 4
Padua 4
Paris 4
Porto Alegre 4
Querétaro 4
Riyadh 4
San José 4
Tianjin 4
Tirana 4
Verona 4
Amsterdam 3
Augusta 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
Boston 3
Bắc Giang 3
Da Nang 3
Duhok 3
Duque de Caxias 3
Erbil 3
Fort Lauderdale 3
Fortaleza 3
Goiânia 3
Grand Rapids 3
Totale 1.770
Salva come PNG Salva come JPEG
Nome #
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 144
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 135
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 130
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 104
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 102
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 100
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 94
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 90
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 90
SARS-CoV-2 infection in aplastic anemia 90
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 85
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 83
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 82
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending? 80
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question" 78
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 78
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 76
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 75
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 71
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 69
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 66
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation 65
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 61
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 61
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 60
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 60
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 60
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 59
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 58
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 58
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 54
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 53
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 51
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 50
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 49
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 49
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 48
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus" 47
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 41
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 40
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 39
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 38
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 37
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 36
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 35
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 35
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 34
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 33
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 31
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study 30
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 29
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm 28
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 26
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission 16
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 10
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study With External Comparison to the Haplo-UK Reduced-Intensity Conditioning Cohort 10
Mogamulizumab as Bridge to Thiotepa-Based Allogeneic Haematopoietic Stem Cell Transplantation in Sézary Syndrome: A Single-Centre Experience 8
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 6
Cytokine Release Syndrome after Haploidentical Transplantation is Associated with Improved Survival Without Increasing Transplant-Related Mortality 5
Totale 3.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 1 0 0 0 0
2023/20244 0 0 0 0 0 1 0 0 2 0 0 1
2024/2025661 0 0 35 92 66 55 89 11 49 35 112 117
2025/20262.550 141 244 142 341 208 171 252 152 188 259 233 219
2026/2027216 214 2 0 0 0 0 0 0 0 0 0 0
Totale 3.432